HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 69 filers reported holding HARVARD BIOSCIENCE INC in Q4 2022. The put-call ratio across all filers is 102.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,700,328 | -17.1% | 613,837 | -23.4% | 0.50% | -18.5% |
| Q3 2022 | $2,051,000 | -28.9% | 801,259 | 0.0% | 0.62% | -23.6% |
| Q2 2022 | $2,885,000 | -5.8% | 801,259 | +62.5% | 0.81% | +17.8% |
| Q1 2022 | $3,063,000 | -11.9% | 493,202 | 0.0% | 0.68% | -3.3% |
| Q4 2021 | $3,477,000 | +50.9% | 493,202 | +49.4% | 0.71% | +110.4% |
| Q3 2021 | $2,304,000 | -19.7% | 330,083 | -4.1% | 0.34% | -18.4% |
| Q2 2021 | $2,868,000 | +660.7% | 344,239 | +178.8% | 0.41% | +390.5% |
| Q4 2019 | $377,000 | -0.8% | 123,470 | 0.0% | 0.08% | +47.4% |
| Q3 2019 | $380,000 | +74.3% | 123,470 | +13.4% | 0.06% | +83.9% |
| Q2 2019 | $218,000 | -53.5% | 108,840 | 0.0% | 0.03% | -56.3% |
| Q1 2019 | $469,000 | – | 108,840 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AMH Equity Ltd | 2,053,907 | $8,626,409 | 9.88% |
| B. Riley Asset Management, LLC | 3,408,796 | $14,316,943 | 5.93% |
| Meros Investment Management, LP | 1,124,206 | $4,721,665 | 2.69% |
| Harvey Partners, LLC | 2,712,700 | $11,393,340 | 1.41% |
| Archon Capital Management LLC | 1,361,769 | $5,719,430 | 1.28% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 2,947,329 | $12,378,782 | 0.80% |
| BARD ASSOCIATES INC | 291,297 | $1,223,448 | 0.50% |
| Portolan Capital Management | 1,043,546 | $4,382,893 | 0.42% |
| HEARTLAND ADVISORS INC | 1,200,000 | $5,040,000 | 0.31% |
| EAM Investors, LLC | 345,546 | $1,451,293 | 0.28% |